kabutan

TAKARA BIO INC., First Half Ordinary Profit Decreases by 66%

Fri Nov 8, 2024 3:00 pm JST Earnings

4974 TAKARA BIO INC. 【J-GAAP】

Earnings Report

TAKARA BIO INC. <4974> [TSE-P] announced its financial results in the afternoon session on November 8th (15:00). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) significantly dropped by 65.6% from the same period last year to 549 million yen. The progress rate against the 5.2 billion yen full-year plan was 10.6%, also falling below the five-year average of 44.7%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to surge by 2.6 times that of the same period last year, reaching 4.65 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit increased by 88.0% from the same period last year, reaching 2.04 billion yen. The operating profit margin drastically improved from 9.9% in the same period last year to 18.2%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 32,587 10,870 10,955 8,538 70.9 53.0 Nov 10, 2022 J-GAAP
Apr - Sep, 2023 19,116 1,410 1,598 1,084 9.0 46.9 Nov 9, 2023 J-GAAP
Apr - Sep, 2024 19,758 417 549 513 4.3 10.6 Nov 8, 2024 J-GAAP
YoY +3.4% -70.4% -65.6% -52.7% -52.7%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance 20,200 150 250 100 0.8 0 May 10, 2024 J-GAAP
Apr - Sep, 2024 Results 19,758 417 549 513 4.3 0 Nov 8, 2024 J-GAAP
Revision Rate -2.2% +178.0% +119.6% +413.0% +413.3%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 24,389 1,593 1,807 396 3.3 17 May 10, 2024 J-GAAP
Oct - Mar, 2024 Guidance 29,142 4,583 4,651 2,887 24.0 17 Nov 8, 2024 J-GAAP
YoY +19.5% +187.7% +157.4% +629.0% +628.9%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 78,142 20,541 20,682 16,012 133.0 42 May 11, 2023 J-GAAP
Mar, 2024 43,505 3,003 3,405 1,480 12.3 17 May 10, 2024 J-GAAP
Mar, 2025 Guidance 48,900 5,000 5,200 3,400 28.2 17 May 10, 2024 J-GAAP
YoY +12.4% +66.5% +52.7% +129.7% +129.6%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 9,940 987 1,089 765 6.4 9.9 Nov 9, 2023 J-GAAP
Oct - Dec, 2023 10,618 -1,074 -1,012 -930 -7.7 -10.1 Feb 14, 2024 J-GAAP
Jan - Mar, 2024 13,771 2,667 2,819 1,326 11.0 19.4 May 10, 2024 J-GAAP
Apr - Jun, 2024 8,493 -1,634 -1,498 -1,047 -8.7 -19.2 Aug 8, 2024 J-GAAP
Jul - Sep, 2024 11,265 2,051 2,047 1,560 13.0 18.2 Nov 8, 2024 J-GAAP
YoY +13.3% +107.8% +88.0% +103.9% +103.9%

Related Articles